hospitals
pharmaceuticals
elite sports
Toumaz has close links with Imperial College, London, has an agreement with Imperial College's Imperial Innovations and is an exploitation partner for ultra-low power microchip and wireless technology.
This future technology pipeline agreement has recently been strengthened by the founding of the new Institute of Biomedical Engineering by Toumaz Chairman and CTO Professor Chris Toumazou, giving Toumaz the opportunity to access all the world's major pharmaceutical and medical device manufacturers.
The New IP Option Agreement with Imperial Innovations grants Toumaz the exclusive right to explore the commercial potential of intellectual property generated within the new Institute of Biomedical Engineering in the field of wireless communications and low power circuit design.
care
latest news
Upcoming event
Toumaz CEO Prof. Chris Toumazou To Speak At The Future World Symposium 2010
Upcoming event
Toumaz CTO Dr Alison Burdett To Address Mobile Healthcare Industry Summit
Upcoming event
Toumaz CEO To Be Keynote Speaker at Wireless Health 2010